Jessica M. Peña i wsp. Statin Therapy and Risk of Fracture: Results From the JUPITER Randomized Clinical Trial, LINK: JAMA Intern Med online
Conclusions and Relevance: Among men and women with elevated hs-CRP level enrolled in a large trial of rosuvastatin therapy for cardiovascular disease, statin therapy did not reduce the risk of fracture. Higher baseline hs-CRP level was not associated with an increased risk of incident fracture.
Opracowane na podstawie: Jama Internal Medicine / 1 grudnia 2014